Associations between circulating neuregulin 4 and diabetic retinopathy in patients with type 2 diabetes mellitus: a cross-sectional study

Neuregulin 4 (Nrg4) is being increasingly recognized as being involved in diabetes biology and vascular injury. Among a cohort of patients with type 2 diabetes mellitus (T2DM), we evaluated whether serum Nrg4 concentrations were related to T2DM and diabetic retinopathy (DR) risk. Serum Nrg4 was assayed by an enzyme-linked immunosorbent assay in 302 adults, including 78 healthy controls and 224 patients with T2DM. DR was evaluated by optical coherence tomography angiography, and T2DM participants were categorized as having non-DR, nonproliferative diabetic retinopathy (NPDR), or proliferative diabetic retinopathy (PDR). We modeled the association between the Nrg4 level and DR using multivariable logistic regression. The predictive ability was summarized with receiver operating characteristic curve analysis. Serum Nrg4 levels in the T2DM group were lower than those in the control group. Compared with that in the NDR group, serum Nrg4 levels were lower in both the NPDR and PDR groups and decreased as DR severity increased. Multivariate logistic regression analysis showed that decreased Nrg4 levels and increased fasting insulin and high-sensitivity C-reactive protein (hs-CRP) were risk factors for T2DM. In the adjusted logistic regression, higher fasting plasma glucose levels and hs-CRP levels and lower Nrg4 levels remained independently associated with DR. When Nrg4 was dichotomized at 3.695 ng/ml in a multivariable model, values above this threshold were associated with a lower DR risk (OR, 0.376; 95% CI, 0.196–0.702; P < 0.01), supporting an independent correlation between Nrg4 and DR. Decreased serum Nrg4 levels are associated with the development of T2DM and DR, and serum Nrg4 levels decrease as DR becomes more severe. This trend suggests that Nrg4 may play a protective role in the development and progression of DR.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-19
DOI
https://doi.org/10.1038/s41598-026-78433-1
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Associations between circulating neuregulin 4 and diabetic retinopathy in patients with type 2 diabetes mellitus: a cross-sectional study

Kaihui Ma, Yanli Hou, Xiang Li, Yikun Zhang et al.
Scientific Reports
Retinal Diseases and Treatments
article

Associations between circulating neuregulin 4 and diabetic retinopathy in patients with type 2 diabetes mellitus: a cross-sectional study

Kaihui Ma, Yanli Hou, Xiang Li, Yikun Zhang, Yan Liu, Yuting Wei, Ke Zhao
article en

Abstract

Neuregulin 4 (Nrg4) is being increasingly recognized as being involved in diabetes biology and vascular injury. Among a cohort of patients with type 2 diabetes mellitus (T2DM), we evaluated whether serum Nrg4 concentrations were related to T2DM and diabetic retinopathy (DR) risk. Serum Nrg4 was assayed by an enzyme-linked immunosorbent assay in 302 adults, including 78 healthy controls and 224 patients with T2DM. DR was evaluated by optical coherence tomography angiography, and T2DM participants were categorized as having non-DR, nonproliferative diabetic retinopathy (NPDR), or proliferative diabetic retinopathy (PDR). We modeled the association between the Nrg4 level and DR using multivariable logistic regression. The predictive ability was summarized with receiver operating characteristic curve analysis. Serum Nrg4 levels in the T2DM group were lower than those in the control group. Compared with that in the NDR group, serum Nrg4 levels were lower in both the NPDR and PDR groups and decreased as DR severity increased. Multivariate logistic regression analysis showed that decreased Nrg4 levels and increased fasting insulin and high-sensitivity C-reactive protein (hs-CRP) were risk factors for T2DM. In the adjusted logistic regression, higher fasting plasma glucose levels and hs-CRP levels and lower Nrg4 levels remained independently associated with DR. When Nrg4 was dichotomized at 3.695 ng/ml in a multivariable model, values above this threshold were associated with a lower DR risk (OR, 0.376; 95% CI, 0.196–0.702; P < 0.01), supporting an independent correlation between Nrg4 and DR. Decreased serum Nrg4 levels are associated with the development of T2DM and DR, and serum Nrg4 levels decrease as DR becomes more severe. This trend suggests that Nrg4 may play a protective role in the development and progression of DR.

Scientific Reports
Shandong University of Traditional Chinese Medicine (CN), Shandong Shierming Eye Hospital (CN), Shandong First Medical University (CN)
Shandong Academy of Medical Sciences
Good health and well-being
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon